Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Levofloxacin, sold under the trade names Levaquin among others, is an antibiotic. It is used to treat a number of bacterial infections including acute bacterial sinusitis, pneumonia, urinary tract infections, chronic prostatitis, and some types of gastroenteritis. Along with other antibiotics it may be used to treat tuberculosis, meningitis, or pelvic inflammatory disease. It is available by mouth, intravenously, and in eye drop form.
Factors such as increasing incidences of bacterial infections such as pneumonia & urinary tract infections (UTI) and broad spectrum efficacy drive the market growth.
However, side effects associated with levofloxacin such as tendon inflammation, psychosis, and seizures restrain the market growth.
Furthermore, rising geriatric population and growing initiatives by the government to spread awareness about severe infections are expected to further drive the market growth.
The global Levofloxacin market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Levofloxacin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Levofloxacin market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Levofloxacin in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Levofloxacin manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Alna Biotech Private
Allenge India Pharma
Bestochem
Divine Savior Healthcare
Glenmark Pharmaceuticals
Pax Healthcare
Aden Healthcare
Lupin Pharmaceuticals
Dr. Reddys Laboratories
Zydus Cadila
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
250 mg
500 mg
750 mg
Segment by Application
Pneumonia
Skin Infection
Kidney Infection
Bladder Infection
Others
Factors such as increasing incidences of bacterial infections such as pneumonia & urinary tract infections (UTI) and broad spectrum efficacy drive the market growth.
However, side effects associated with levofloxacin such as tendon inflammation, psychosis, and seizures restrain the market growth.
Furthermore, rising geriatric population and growing initiatives by the government to spread awareness about severe infections are expected to further drive the market growth.
The global Levofloxacin market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Levofloxacin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Levofloxacin market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Levofloxacin in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Levofloxacin manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Alna Biotech Private
Allenge India Pharma
Bestochem
Divine Savior Healthcare
Glenmark Pharmaceuticals
Pax Healthcare
Aden Healthcare
Lupin Pharmaceuticals
Dr. Reddys Laboratories
Zydus Cadila
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
250 mg
500 mg
750 mg
Segment by Application
Pneumonia
Skin Infection
Kidney Infection
Bladder Infection
Others
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
